David J Hammond

Title: David J Hammond: Innovator in Biochemical Engineering

Introduction

David J Hammond is a prominent inventor based in Raleigh, NC (US). He has made significant contributions to the field of biochemical engineering, particularly in the development of peptides and methods for protein purification and viral inactivation. With a total of 4 patents to his name, Hammond continues to push the boundaries of innovation in his field.

Latest Patents

Hammond's latest patents include groundbreaking work on peptides that bind to prothrombin and thrombin. These peptide ligands, which include sequences such as Gln-Leu-Trp-Gly-Ser-His and Tyr-Phe-Pro-Gly-Pro-Tyr-Leu, are designed to enhance the purification process of thrombin through affinity chromatography. Additionally, he has developed a method for the selective stabilization of proteins during viral inactivation. This process involves binding biologically active proteins to immobilized ligands, allowing for effective viral inactivation while preserving the protein's biological activity.

Career Highlights

David J Hammond is currently employed at Bayer Corporation, where he applies his expertise in biochemical engineering to advance innovative solutions. His work has not only contributed to the scientific community but has also had practical applications in the pharmaceutical industry.

Collaborations

Hammond has collaborated with notable colleagues, including George A Baumbach and Christopher A Dadd. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

David J Hammond is a distinguished inventor whose work in peptide development and protein purification has made a significant impact in the field of biochemical engineering. His innovative patents and collaborations continue to shape the future of this important area of research.